3 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Nephrogenic Diabetes Insipidus: new trials by email Literature Review of Nephrogenic Diabetes Insipidus trials Research Report on Nephrogenic Diabetes Insipidus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children Measure of Basal Copeptin level, Measure of arginine-stimulated copeptin, IRM - Primary Polydipsia, Central Diabetes Insipidus | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 155 | 2025-03-01 | 2025-02-13 |
| Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration PB - Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus | Phase 2 | Completed | Mayo Clinic | 36 | 2022-09-01 | 2026-01-27 |
| Decline in Renal Concentration Ability in Lithium Treated Patients Deamino Arginine Vasopressin (dDAVP) - Lithium Toxicities, Bipolar Disorder | Unknown | Radboud University Medical Center | 51 | 2022-05-01 | 2022-04-01 | |
| Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis Sevoflurane - Nephrogenic Diabetes Insipidus | Completed | Universitair Ziekenhuis Brussel | 1000 | 2021-05-26 | 2023-04-27 | |
| National Registry of Rare Kidney Diseases Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis | Recruiting | UK Kidney Association | 35000 | 2009-11-06 | 2023-10-04 | |
| Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus sildenafil, calcitonin, hydrochlorothiazide/amiloride - Nephrogenic Diabetes Insipidus | Not applicable | Completed | University of Colorado, Denver | 4 | 2007-05-01 | 2018-02-12 |
Diabetes Insipidus, Nephrogenic (6) · Polycystic Kidney, Autosomal Dominant (2) · Adenine phosphoribosyltransferase deficiency (1) · Atypical Hemolytic Uremic Syndrome (1) · Bartter Syndrome (1) · Bipolar Disorder (1) · Calciphylaxis (1) · Cystinosis (1) · Cystinuria (1) · Dent Disease (1) · Denys-Drash Syndrome (1) · Diabetes Insipidus (1) · Diabetes Insipidus, Neurogenic (1) · Fabry Disease (1) · Fibromuscular Dysplasia (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Kidney Diseases (6) · Male Urogenital Diseases (6) · Urogenital Diseases (6) · Urologic Diseases (6) · Diabetes Insipidus (5) · Endocrine System Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Abnormalities, Multiple (2) · Ciliopathies (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Kidney Diseases, Cystic (2)
Calcitonin (1) · Indomethacin (1) · Sevoflurane (1) · Sildenafil Citrate (1) · amiloride, hydrochlorothiazide drug combination (1) · salmon calcitonin (1)
Assistance Publique Hopitaux De Marseille (1) · Mayo Clinic (1) · Radboud University Medical Center (1) · UK Kidney Association (1) · Universitair Ziekenhuis Brussel (1) · University of Colorado, Denver (1)
United States (2) · Belgium (1) · Denmark (1) · France (1) · Netherlands (1) · United Kingdom (1)
Fouad Chebib, MD (1) · Melissa A Cadnapaphornchai, MD (1) · T. Nijenhuis (1)